NCT02096744 - Bioequivalence of Two Transdermal Clonidine Administrations in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Healthy

Interventions

DRUG

Catapres-TTS-1

Catapres-TTS-1 Oppanol

DRUG

Intervention 1: Catapres-TTS-3

Catapres-TTS-3 Oppanol

DRUG

Intervention 1: Catapres-TTS-3

Catapres-TTS-3 Oppanol

DRUG

Intervention 2: Catapres-TTS-3

Catapres-TTS-3 Vistanex

DRUG

Catapres-TTS-1

Catapres-TTS-1 Vistanex

DRUG

Intervention 2: Catapres-TTS-3

Catapres-TTS-3 Vistanex

Trial Locations (1)

253.2486.1 Boehringer Ingelheim Investigational Site, Austin